OncoSenX logo

OncoSenX jobs and careers

Seattle, WA, United States

About OncoSenX

OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.

Founded in 2017 by John Lewis and Matthew Scholz.

Founded
2017
Employees
1 to 10
Total funding
$11.7M
Headquarters
Seattle

Leadership

The top of OncoSenX's org chart, with how many people report into each leader.

MSPhoto of Matthew Scholz

Matthew Scholz

CEO

4 reports

JLPhoto of John D. Lewis

John D. Lewis

Founder, CSO

1 report

SHPhoto of Stephen Hilbert

Stephen Hilbert

Chief Business Officer

EGPhoto of Eric Garcia

Eric Garcia

COO

Board

GHPhoto of Gary C. Hudson

Gary C. Hudson

Board Member